2024-10-17 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**1. Performance Comparison:**

CVS Health Corp (CVS) has underperformed the S&P 500 (VOO) significantly, with a cumulative return of -30.46% compared to VOO's 135.94%. This represents a -166.4% difference, placing it at the 71st percentile of its historical performance range.

**2. Recent Price Movement:**

* **Closing Price:** $65.0
* **5-day Moving Average:** $66.42
* **20-day Moving Average:** $62.33
* **60-day Moving Average:** $59.53

CVS is currently trading above its 5, 20, and 60-day moving averages, suggesting potential upward momentum.

**3. Technical Indicators:**

* **RSI:** 71.48 - Indicates the stock is in overbought territory, suggesting a potential correction.
* **PPO:** 0.54 - Indicates a strong upward momentum, suggesting potential continued gains.
* **Delta_Previous_Relative_Divergence:** -0.32 - Suggests a recent short-term downtrend.
* **Expected_Return:** 0.0% -  The expected return over the next 5 years is estimated to be 0.0% above the S&P 500 (VOO) benchmark, based on current investment levels.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

CVS has consistently exceeded earnings expectations in recent quarters, demonstrating strong performance. However, the latest earnings report showed a slight decline in EPS compared to the previous quarter.

**5. News and Recent Issues:**

According to FINBOLD, CVS Health Corp (CVS) is facing a number of challenges, including increasing competition in the healthcare industry, rising costs, and concerns about prescription drug pricing.  However, the company is also benefiting from the growing demand for healthcare services and is investing in new technologies, such as digital pharmacy and telehealth.

**6. Summary:**

CVS Health Corp (CVS) is a large pharmacy chain that has been struggling to keep up with the S&P 500 (VOO). While it has shown strong recent earnings, its performance has been volatile and it is currently in overbought territory. Despite facing challenges, the company remains optimistic about the future, particularly in the areas of digital pharmacy and telehealth.

**7. Conclusion:**

CVS Health Corp is a company with potential, but it is facing numerous challenges. Investors should carefully consider the company's long-term prospects and its ability to overcome these challenges before making an investment decision. 
